PQ912

· Vivoryon Therapeutics N.V.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for PQ912, covering 2015-10-21 to 2025-12-12. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD [Phase 2]